secwatch.observer — SEC 8-K summary
======================================

Issuer:     Atara Biotherapeutics, Inc. (ATRA)
CIK:        0001604464
Form:       8-K
Filed at:   2025-09-04T23:59:59+00:00
Accession:  0000950170-25-112898
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Three directors resign from Atara Biotherapeutics board; Ciongoli named Chair
-----------------------------------------------------------------------------

- Directors Ameet Mallik, Pascal Touchon, and Maria Grazia Roncarolo resigned voluntarily effective Sept 2, 2025.
- Board size reduced from 10 to 7 directors as of the same date.
- Gregory A. Ciongoli appointed as Chair to succeed Pascal Touchon.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1604464/000095017025112898/0000950170-25-112898-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1604464/000095017025112898/atra-20250902.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-112898

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer